It has been shown that the use of celecoxib, a selective COX-2 inhibitor, in combination with the STING agonist cyclic GMP-AMP (cGAMP) induced an anti-cancer immunity in mouse tumor models. The gene discussed is STING1; the disease is neoplasm.